Search

Scleroderma Life Hacks

Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms. Part of the global 'More Than Scleroderma' initiative developed by Boehringer Ingelheim, with support from patient organi

A beginner’s guide to fighting off cat parasites

Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats

Partnering with Lifebit to detect global disease outbreaks

Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks

PRRS vaccine celebrates 25 years in Europe

Boehringer Ingelheim celebrates 25 years to combat PRRS in Europe

Boehringer Ingelheim Ruminant Well-Being Awards 2020

The World Association for Buiatrics and Boehringer Ingelheim announce the Ruminant Well-Being Awards.

Reduction of Salmonella in swine after vaccination

Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis

Boehringer Ingelheim partners with PetMedix

Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals

EMA authorization for Reprocyc ParvoFLEX

Boehringer Ingelheim obtains EMA authorization for Reprocyc® ParvoFLEX, a new porcine parvovirus vaccine

Boehringer Ingelheim opens Health Management Centre in China

Boehringer Ingelheim opens Health Management Centre in China The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools The centre further strengthens the company’s ability to provide services along the f

Life stages of cats

Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better.

Tackling supply chain challenges for a country at war

We are there for our patients – even in crisis regions. A supply chain success story with our Ukrainian colleague Tetiana Nagirna from Kyiv.

Boehringer Ingelheim invests in precision cancer treatments

Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies

FDA Grants Breakthrough Status to Schizophrenia Treatment

Boehringer Ingelheim and Click Therapeutics receive FDA Breakthrough Device Designation for schizophrenia prescription digital therapeutic

Human-dog relationship – a historical perspective

The human-dog relationship – a historical perspective

Groundbeaking of vaccine production center in France

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

Winners of BVDzero Scholarship Programme

Boehringer Ingelheim announces winners of BVDzero Scholarship Programme

Boehringer Ingelheim and Fraunhofer partnership

Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products

Henke-Sass Wolf develop needle free device

Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs

Survey with Ipsos to gain insights human-animal bond

Boehringer Ingelheim partnered with the Ipsos Research Institute to carry out a survey to explore the human-animal bond.

GastroGard the first imported equine drug in China

GastroGard® approved as the first imported equine drug in China. Boehringer Ingelheim officially starts equine health business in China.

Winners of 2020 BVDzero Case Awards

Winners of 2020 BVDzero Case Awards announced. 10 top clinical cases will receive a total prize of 15,000 euros.

Spesolimab meets key endpoint for GPP flare prevention

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

Groundbreaking oncology research zongertinib

Boehringer Ingelheim to unveil groundbreaking oncology research at WCLC, demonstrating strength of portfolio

Dedifferentiated liposarcoma (DDLPS)

An aggressive subtype of a category of cancers called soft tissue sarcoma (STS). DDLPS has a poor prognosis and limited treatment options.

Patient centricity and site centricity in clinical trials

We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers